31st Edition Strategic Project & Portfolio Management for Pharma

This conference will explore how European pharmaceutical PMO and portfolio leaders can strengthen prioritisation, reinforce decision independence, and improve data readiness across the portfolio. Sessions will highlight governance approaches that keep decision review rigorous and independent, the discipline to invest, wait, or stop across every pipeline stage, a single trusted source of truth for portfolio data, and where AI and agile can genuinely add value to portfolio decisions. The agenda will also deliver practical guidance on resource allocation and final decision authority within matrix organisations, helping PPM leaders close the gap between portfolio planning, governance, resourcing, and delivery. Delegates will leave with actionable frameworks to strengthen PPM’s influence and impact across their organisation.